Nov 3, 2026 07:12AM
Oct 5, 2026 05:04AM
Sep 24, 2026 05:32AM
Sep 21, 2026 10:04AM
Sep 21, 2026 08:16AM
Sep 1, 2026 03:55AM
Jul 31, 2026 09:00AM Weakness in this biotech stock is a buying opportunity: Mizuho
Jul 30, 2026 06:51AM
Jul 28, 2026 08:22AM
Jul 28, 2026 07:10AM
Jul 20, 2026 05:14AM
Jul 13, 2026 09:20AM
Jul 13, 2026 07:01AM
Jul 13, 2026 03:13AM JPMorgan Resumes Alkermes (ALKS) at Neutral
Jul 8, 2026 08:10AM
Jul 2, 2026 05:04AM
Jun 29, 2026 06:15AM
Jun 18, 2026 07:06AM
Jun 18, 2026 06:43AM
Jun 15, 2026 07:02AM
Jun 9, 2026 08:36AM Alkermes (ALKS) PT Raised to $56 at RBC Capital; 'Don't Sleep On The Pipeline'
May 12, 2026 09:30AM
May 5, 2026 12:28PM
May 5, 2026 07:13AM
Apr 14, 2026 07:00AM
Apr 10, 2026 06:52AM
Mar 24, 2026 08:52AM
Mar 10, 2026 08:24AM Truist Securities Reiterates Buy Rating on Alkermes (ALKS): "remains one of our highest conviction BUY rated stocks"
Feb 26, 2026 06:39AM
Feb 25, 2026 07:19AM
Jan 28, 2026 02:16AM
Jan 6, 2026 07:04AM
Nov 20, 2025 06:40AM
Nov 17, 2025 05:52AM
Nov 17, 2025 04:19AM Alkermes (ALKS) PT Raised to $55 at Truist Securities
Nov 14, 2025 07:45AM
Nov 14, 2025 05:45AM
Nov 13, 2025 04:37AM
Nov 12, 2025 01:05PM
Nov 12, 2025 12:37PM
Nov 12, 2025 10:52AM
Nov 12, 2025 09:57AM Truist Securities Defends Alkermes (ALKS) Amid 10pct Drop: 'We are buyers of the weakness today'
Nov 11, 2025 06:05AM
Nov 5, 2025 12:22PM
Nov 5, 2025 08:03AM
Nov 5, 2025 07:55AM
Oct 28, 2025 03:19PM
Oct 28, 2025 01:16PM
Oct 28, 2025 07:02AM Alkermes (ALKS) Tops Q3 EPS by 11c
Oct 27, 2025 06:43AM

490,330 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All